Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
Asami Ikeda, Ken Yamaguchi, Hajime Yamakage, Kaoru Abiko, Noriko Satoh-Asahara, Kenji Takakura, Ikuo Konishi
Obstet Gynecol Sci. 2020;63(6):709-718.   Published online 2020 Sep 17     DOI:
Citations to this article as recorded by Crossref logo
Novel nutritional indicator as predictors among subtypes of lung cancer in diagnosis
Haiyang Li, Zhangkai J. Cheng, Zhiman Liang, Mingtao Liu, Li Liu, Zhenfeng Song, Chuanbo Xie, Junling Liu, Baoqing Sun
Frontiers in Nutrition.2023;[Epub]     CrossRef
The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review
Xin Wang, Shiyuan Wang, Shujuan Yao, Wei Shi, Ke Ma
Journal of Ovarian Research.2022;[Epub]     CrossRef
Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: A promise towards disease remission
Komal Tyagi, Supratim Mandal, Adhiraj Roy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1876(1): 188563.     CrossRef
Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management
Mohammad Aslam Khan, Kunwar Somesh Vikramdeo, Sarabjeet Kour Sudan, Seema Singh, Annelise Wilhite, Santanu Dasgupta, Rodney Paul Rocconi, Ajay Pratap Singh
Seminars in Cancer Biology.2021; 77: 99.     CrossRef
Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment
Racheal Johnson, Michele Cummings, Amudha Thangavelu, Georgios Theophilou, Diederick de Jong, Nicolas Orsi
Cancers.2021; 13(24): 6231.     CrossRef